Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-050134
Filing Date
2026-07-28
Accepted
2026-07-28 16:02:56
Documents
80
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abt-20260630.htm   iXBRL 10-Q 1580277
2 EX-31.1 q2202610qex311.htm EX-31.1 9394
3 EX-31.2 q2202610qex312.htm EX-31.2 9384
4 EX-32.1 q2202610qex321.htm EX-32.1 5157
5 EX-32.2 q2202610qex322.htm EX-32.2 4963
  Complete submission text file 0001628280-26-050134.txt   9406224

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abt-20260630.xsd EX-101.SCH 52484
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abt-20260630_cal.xml EX-101.CAL 72226
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abt-20260630_def.xml EX-101.DEF 314851
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abt-20260630_lab.xml EX-101.LAB 668979
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abt-20260630_pre.xml EX-101.PRE 481942
84 EXTRACTED XBRL INSTANCE DOCUMENT abt-20260630_htm.xml XML 1850578
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-02189 | Film No.: 261211773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)